Amaya García-Fernández

Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

Andrea Mazzanti, Dmitri Guz, Alessandro Trancuccio et al. · Journal of the American College of Cardiology · 2020 · 82 citations · Full text

Life Sciences, Genetics, Neurology +8

Time-to-Effect–Based Dosing Strategy for Cryoballoon Ablation in Patients With Paroxysmal Atrial Fibrillation

Ángel Ferrero‐de‐Loma‐Osorio, Amaya García-Fernández, Jesús Castillo‐Castillo et al. · Circulation Arrhythmia and Electrophysiology · 2017 · 62 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

Amaya García-Fernández, Vanessa Roldán, José Miguel Rivera‐Caravaca et al. · Scientific Reports · 2017 · 35 citations · Full text

Medicine, Cardiology, Clinical Sciences +17

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

María Asunción Esteve‐Pastor, Amaya García-Fernández, Manuel Macı́as et al. · Circulation Journal · 2016 · 26 citations · Full text

Medicine, Cardiology, Hematology +16

Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA₂DS₂-VASc and HAS-BLED scores using multiple biomarkers

Vanessa Roldán, José Miguel Rivera‐Caravaca, Alena Shantsila et al. · Annals of Medicine · 2017 · 24 citations

Medicine, Cardiology, Clinical Pharmacology +16